Skip to content

CDR

WBA-Rite Aid divestitures could total up to 1,000

WBA-Rite Aid divestitures could total up to 1,000

Walgreens Boots Alliance (WBA) Inc. has indicated that as many as 1,000 stores could be divested to gain regulatory approval for its deal to acquire Rite Aid Corp. In an investor presentation filed Monday with the Securities and Exchange Commission, WBA said the the $17.

Mylan names GSK veteran as global OTC leader

Mylan names GSK veteran as global OTC leader

Mylan N.V. has tabbed GlaxoSmithKline Consumer Healthcare veteran Ranjan Ray Chaudhuri to serve as global commercial lead of Mylan’s over-the-counter business. Chaudhuri will report to Rajiv Malik, president of Mylan.

CVS in-store campaign supports cancer research

CVS in-store campaign supports cancer research

CVS/pharmacy has kicked its second annual in-store fundraising campaign to benefit the cancer research group Stand Up To Cancer (SU2C). CVS said Monday that the campaign, which features actress and SU2C ambassador Eva Longoria, is part of a three-year, $10 million commitment by CVS Health to SU2C.

Diva International sales exec promoted to VP

Diva International sales exec promoted to VP

John Szustaczek has been promoted to vice president of sales and marketing, Diva International Inc., maker of The DivaCup. Diva said Monday that Szustaczek has played an integral role in the growth of the menstrual care product company since joining it in 2012 as director of sales and marketing.

Sanofi recalls all Auvi-Q epinephrine injectors

Sanofi recalls all Auvi-Q epinephrine injectors

Sanofi US has voluntarily recalled all Auvi-Q epinephrine injectors, used for the emergency treatment of anaphylaxis, a serious allergic reaction. Sanofi said Friday that the recall involves all Auvi-Q currently on the market and includes both the 0.15 mg and 0.

CVS, Rite Aid to buy A&P store Rx files

CVS, Rite Aid to buy A&P store Rx files

CVS Health and Rite Aid have confirmed agreements to purchase prescription files from A&P stores in the Northeast. A&P filed for Chapter 11 bankruptcy protection this summer and has since been closing and selling off stores.

CVS Health reports rise in revenue for 3Q

CVS Health reports rise in revenue for 3Q

CVS Health posted sales gains in both its retail pharmacy and pharmacy services businesses for the 2015 third quarter, with adjusted earnings per share (EPS) finishing in line with analysts’ projections.

Analysts dissect Walgreens-Rite Aid deal

Analysts dissect Walgreens-Rite Aid deal

Zacks Investment Research stock strategists Tracey Ryniec and David Bartosiak discussed with Zacks’ Terry Ruffolo the Walgreens Boots Alliance’s proposal to acquire Rite Aid Corp. for $9 per share in cash, and assumption of debt, for a total value of $17.2 billion.

PTCB marks its 20th anniversary

PTCB marks its 20th anniversary

This week, the Pharmacy Technician Certification Board (PTCB) hosted a special 20th anniversary reception to celebrate two decades of advancing patient care and safety and to recognize the 2015 PTCB Certified Pharmacy Technician (CPhT) of the Year.

Kroger pharmacy VP honored with award

Kroger pharmacy VP honored with award

Kroger Co. vice president of pharmacy Philecia Avery was recognized by the National Diversity Council with a 2015 Most Powerful & Influential Women Award. Kroger said Thursday that Avery was presented with the award at the 8th Annual Ohio Diversity & Leadership Conference in Columbus, Ohio.

Rite Aid sees same-store sales uptick in October

Rite Aid sees same-store sales uptick in October

Comparable pharmacy results helped offset a same-store sales dip in the front end at Rite Aid Corp. for October. Rite Aid said Thursday that for the four weeks ended Oct. 24, comparable-store sales inched up 1% year over year, reflecting a 0.5% decrease in the front end and a 1.7% gain

Allergan, Pfizer: We’re in discussions

Allergan, Pfizer: We’re in discussions

Allergan plc and Pfizer Inc. have confirmed they’re exploring a possible combination. Dublin, Ireland-based Allergan released a statement Thursday saying it’s in early talks with Pfizer about a possible deal, and Pfizer later affirmed Allergan’s statement.